DE MURO, Pierina
 Distribuzione geografica
Continente #
NA - Nord America 1.733
EU - Europa 1.141
AS - Asia 564
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
SA - Sud America 6
AF - Africa 4
Totale 3.463
Nazione #
US - Stati Uniti d'America 1.723
CN - Cina 528
UA - Ucraina 510
DE - Germania 171
IT - Italia 115
SE - Svezia 92
FI - Finlandia 83
FR - Francia 66
BE - Belgio 46
GB - Regno Unito 42
TR - Turchia 26
CA - Canada 9
EU - Europa 8
AU - Australia 6
BR - Brasile 5
CZ - Repubblica Ceca 5
IL - Israele 3
JP - Giappone 3
PL - Polonia 3
EG - Egitto 2
HR - Croazia 2
AO - Angola 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SG - Singapore 1
SI - Slovenia 1
TH - Thailandia 1
VN - Vietnam 1
Totale 3.463
Città #
Chandler 435
Jacksonville 316
Princeton 158
Nanjing 147
Dearborn 104
Ann Arbor 83
Wilmington 72
Nanchang 65
New York 60
Sassari 59
Brussels 46
Boardman 43
Beijing 42
Shenyang 42
Hebei 39
Woodbridge 31
Changsha 30
Ningbo 26
Tianjin 23
Izmir 22
Mountain View 22
Hangzhou 21
Jinan 19
Jiaxing 17
Zhengzhou 17
Kunming 14
Andover 13
Norwalk 13
Ashburn 10
Toronto 8
Guangzhou 7
San Francisco 7
Villiers-sur-marne 7
Auburn Hills 6
Helsinki 6
Lanzhou 6
Los Angeles 6
Taizhou 6
Brno 5
Changchun 5
Falls Church 3
Melbourne 3
Paris 3
Verona 3
Warsaw 3
Cagliari 2
Cairo 2
Canberra 2
Cedar Knolls 2
Edinburgh 2
Fairfield 2
Hanover 2
London 2
San Jose 2
San Mateo 2
Serramanna 2
São Paulo 2
Tappahannock 2
Tel Aviv 2
Tokyo 2
Turin 2
Zagreb 2
Adelaide 1
Agadir 1
Americo Brasiliense 1
Amsterdam 1
Augusta 1
Bangkok 1
Berlin 1
Chernihiv 1
Denver 1
Ficarazzi 1
Fredericton 1
Haifa 1
Haikou 1
Hanoi 1
Leawood 1
Ljubljana 1
Mexico City 1
Miami 1
Milan 1
New Plymouth 1
Potenza 1
Rome 1
Santa Clara 1
Seelze 1
Singapore 1
Sofia 1
Totale 2.133
Nome #
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 77
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 75
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 68
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 67
Hb G-Philadelphia, or [alpha68(E17)AsnLys], in North Sardinia: detection by isoelectric focusing and HPLC of tryptic peptides 66
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 66
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 64
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 63
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 61
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 61
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 60
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 59
Haematological and biosynthetic features of beta°-thalassemia with an associated alpha-thalassemia heterozygosity in Sardinia 58
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 56
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 56
Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity 52
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 52
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 51
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 51
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 50
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 50
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 49
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 49
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 49
Urinary excretion of GAGs during hypocholesterolemic therapy 48
A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients 47
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 45
Role of the small proteoglycan bikunin in human reproduction 45
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 45
Buoyant density of Lp(a) subclasses in hypercholesterolemia 45
The gamma globin chain heterogeneity of the Sardinian newborn baby. Hemoglobin, 10:519-528, 1986. 45
Apolipoprotein Profiles in Atherosclerotic Disease 44
Apolipoprotein Profiles in Atherosclerotic Disease 44
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 44
GAG and protein composition of GAG-protein complexes from normal human plasma 43
Urinary transaforming growth factor beta 1 in various types of nephropathy 42
Atherosclerotic modifications of human proteoglycans 42
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 42
Ruolo dei proteoglicani nella medicina della riproduzione 42
Urinary glycosaminoglycan composition in chronic glomerulonephritis 42
Proteoglicani e diabete gestazionale: dati preliminari 42
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 41
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 41
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 40
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 40
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 40
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 39
Glycosaminoglycan biodiversity in W-Mediterranean marine sponges. 39
Post-translational modifications of proteoglycans during the development of atherosclerotic lesion 39
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 39
Plasma GAG-protein complexes modify chemical and physical properties of human LDL 39
Investigations on PGs extracted from human aorta of different age and with different atherosclerotic lesions 38
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 38
Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes 38
Preliminary investigations of LDL interactions with proteoglycans extracted from human aortic walls with different atherosclerotic lesions 38
The gamma globin chain heterogeneity of the Sardinian newborn baby 37
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 37
Urinary glycosaminoglycansin patients with systemic lupus erytematosus 36
Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis 36
Glycosamynoglycan diversity in sponge extracellular matrix 35
Urine bikunin as a marker of renal impairment in Fabry's disease 35
DNA polymorphisms in North Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with betao-thalassemia. 35
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 33
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 33
Diversità molecolare negli invertebrati marini: screening dei glicosaminoglicani in spugne del Mediterraneo occidentale 33
Modification of low density lipoprotein induced by the interaction with standard GAGs 33
Glycosaminoglycan diversity in sponge extracellular matrix 32
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 32
Blood and urine glycosaminoglycan variations during different hypocholesterolemic therapies in type 2 diabetic patients 31
Evidences that atherosclerotic lesion involves modifications of arterial wall proteoglycans, affecting their interactions with LDL 31
Hematological and biosynthetic features of betao-thalassemia with an associated beta-thalassemia heterozygosity in Sardinia. 30
Urinary transforming growth factor-beta 1 in various types of nephropathy 30
Glycosaminoglycans and fabry’s disease 30
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 30
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 30
Human LDL binding to plasma high charge glycosaminoglycan-protein complexes 28
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 28
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 27
Sulphated polysaccharide content and localization in some marine sponge species. 25
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 25
Totale 3.498
Categoria #
all - tutte 12.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019179 0 0 0 0 0 0 0 0 0 6 1 172
2019/2020861 236 2 78 8 89 89 133 10 89 31 96 0
2020/2021606 84 5 98 8 82 19 85 4 95 98 16 12
2021/2022396 62 3 0 11 6 2 24 26 46 25 39 152
2022/2023817 84 54 14 149 82 141 5 94 131 15 29 19
2023/2024203 49 20 8 9 55 50 1 11 0 0 0 0
Totale 3.498